General InformationVenus Concept Inc. is a Toronto, Canada-based publicly traded medical aesthetics company with approximately 400+ employees, founded in 2004, specializing in non-invasive aesthetic device platforms.
Funding & FinancialsThe company is publicly traded on the NASDAQ under ticker symbol VCON; it has raised over $500 million through various funding rounds and public offerings since inception.
Leadership & TeamLed by CEO Domenic Serafino, the company has experienced leadership in medical device commercialization and aesthetic medicine sectors.
Recent ActivityRecent focus has been on expanding the Venus Versa and Venus Legacy product lines globally, with ongoing clinical studies validating efficacy for skin rejuvenation and body contouring applications.